Head-to-head · WeighScore
Invigor Medical vs Peter MD
By GLP-1 ScorecardUpdated
Score comparison
Invigor Medical has the higher recorded score — 86.1/100 to 78.1/100.
Invigor Medical grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Now Try Invigor, this platform advertises class-based GLP-1 plans; confirm your medicine and supply before accepting its starting price.
Before you choose
Before comparing the headline prices, the Invigor Medical review and the Peter MD review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Invigor Medical vs Pomegranate Health and Ondra Health vs Peter MD compare each of them with another graded program, and the list of alternatives to Invigor Medical ranks the programs closest to Invigor Medical on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Invigor Medical | Peter MD |
|---|---|---|
| WeighScore | 86.1/100 | 78.1/100 |
| Grade | B | C+ |
| Site position | #9 | #32 |
| Semaglutide | Medication-specific quote unconfirmed; public GLP-1 treatment starts at $225. | From $149/month advertised with B12; other page prices differ; confirm charge and renewal |
| Tirzepatide | Medication-specific quote unconfirmed; public GLP-1 + GIP treatment starts at $350/month. | From $149/month with B12; $100 off first month advertised; renewal unconfirmed |
| Coverage | U.S. only; confirm medication-specific state availability | Confirm availability for the specific GLP-1 prescription and shipping state |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Consultation, medication and supplies advertised together
- Ordinary and microdose treatment listings are separately presented
- Clinical policy describes virtual consultation and relevant testing when needed
What to consider
- Current medication-specific dose and supply quote is unconfirmed
- Cancel new orders before the prescription enters the practitioner's queue
- Subscriptions need seven days’ notice before renewal processing; charges may occur early
- No universal GLP-1 lab panel, frequency or separate testing price published
Site position #32 · C+
Strengths
- Dedicated offers advertise consultations, supplies, shipping and membership together
- Public pages name pharmacy possibilities and disclose an email cancellation window
- Laboratory testing is advertised at 50% off
What to consider
- Starting prices do not establish the renewal; main-site price displays differ
- Specific GLP-1 state eligibility, assigned clinician and dispensing pharmacy remain unconfirmed
- Labs are discounted rather than free; GLP-1-specific monitoring and total testing cost remain unclear
- Auto-renewal cancellation requires at least 48 hours’ email notice; sales are final once medication is received
- Clinical rejection and unused-prepayment refund terms remain unresolved
Featured provider
Peter MD
Peter MD scores 78.1/100 (C+). Peter MD advertises B12 injection packages with consultations, supplies and shipping, but its public price displays differ and the ongoing GLP-1 charge needs a written quote.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.